Encompass Health Co. (NYSE:EHC) Stake Raised by Stifel Financial Corp

Stifel Financial Corp increased its holdings in Encompass Health Co. (NYSE:EHC) by 8.9% in the third quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 60,984 shares of the company’s stock after buying an additional 4,966 shares during the quarter. Stifel Financial Corp’s holdings in Encompass Health were worth $5,893,000 at the end of the most recent reporting period.

Several other large investors have also recently added to or reduced their stakes in EHC. UMB Bank n.a. raised its position in shares of Encompass Health by 387.7% during the 3rd quarter. UMB Bank n.a. now owns 317 shares of the company’s stock worth $31,000 after buying an additional 252 shares in the last quarter. V Square Quantitative Management LLC raised its holdings in Encompass Health by 53.0% during the third quarter. V Square Quantitative Management LLC now owns 404 shares of the company’s stock worth $39,000 after purchasing an additional 140 shares in the last quarter. Avior Wealth Management LLC acquired a new stake in Encompass Health in the third quarter worth approximately $40,000. Benjamin F. Edwards & Company Inc. boosted its stake in Encompass Health by 58.9% during the 2nd quarter. Benjamin F. Edwards & Company Inc. now owns 534 shares of the company’s stock valued at $46,000 after purchasing an additional 198 shares in the last quarter. Finally, Point72 Asia Singapore Pte. Ltd. acquired a new position in shares of Encompass Health during the 2nd quarter valued at $58,000. 97.25% of the stock is currently owned by institutional investors and hedge funds.

Encompass Health Stock Performance

Shares of EHC stock opened at $98.19 on Friday. The company has a market capitalization of $9.89 billion, a price-to-earnings ratio of 23.72, a P/E/G ratio of 1.34 and a beta of 0.86. Encompass Health Co. has a 1-year low of $65.33 and a 1-year high of $104.55. The company has a current ratio of 1.04, a quick ratio of 1.04 and a debt-to-equity ratio of 0.88. The stock’s fifty day simple moving average is $99.35 and its 200-day simple moving average is $92.55.

Encompass Health (NYSE:EHC) last released its earnings results on Monday, October 28th. The company reported $1.03 earnings per share for the quarter, beating the consensus estimate of $0.94 by $0.09. The company had revenue of $1.35 billion for the quarter, compared to analysts’ expectations of $1.33 billion. Encompass Health had a return on equity of 17.60% and a net margin of 8.10%. The business’s revenue for the quarter was up 11.9% on a year-over-year basis. During the same quarter in the previous year, the business posted $0.86 EPS. On average, sell-side analysts predict that Encompass Health Co. will post 4.29 earnings per share for the current fiscal year.

Encompass Health Dividend Announcement

The business also recently announced a quarterly dividend, which will be paid on Wednesday, January 15th. Shareholders of record on Thursday, January 2nd will be paid a dividend of $0.17 per share. This represents a $0.68 dividend on an annualized basis and a dividend yield of 0.69%. The ex-dividend date of this dividend is Thursday, January 2nd. Encompass Health’s dividend payout ratio (DPR) is currently 16.43%.

Analysts Set New Price Targets

EHC has been the subject of several research reports. KeyCorp raised their target price on Encompass Health from $115.00 to $117.00 and gave the company an “overweight” rating in a research note on Tuesday, October 29th. Royal Bank of Canada raised their price objective on shares of Encompass Health from $105.00 to $110.00 and gave the company an “outperform” rating in a research report on Wednesday, October 30th. Barclays boosted their target price on shares of Encompass Health from $109.00 to $116.00 and gave the stock an “overweight” rating in a report on Tuesday, October 29th. UBS Group raised their target price on shares of Encompass Health from $100.00 to $110.00 and gave the stock a “buy” rating in a report on Wednesday, September 25th. Finally, Truist Financial reaffirmed a “buy” rating and issued a $116.00 price target (up previously from $108.00) on shares of Encompass Health in a report on Wednesday, October 30th. Nine equities research analysts have rated the stock with a buy rating and two have given a strong buy rating to the company’s stock. According to data from MarketBeat, the company has an average rating of “Buy” and an average price target of $107.11.

About Encompass Health

Encompass Health Corporation provides post-acute healthcare services in the United States and Puerto Rico. It owns and operates inpatient rehabilitation hospitals that provide medical, nursing, therapy, and ancillary services. The company provides specialized rehabilitative treatment on an inpatient basis to patients who have experienced physical or cognitive disabilities or injuries due to medical conditions, such as strokes, hip fractures, and various debilitating neurological conditions.